EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

New insights into the pharmacological inhibition of SRF activity: Key inhibitory targets and mechanisms

Daniel Wong, Hongyu Qiu

Vascular Pharmacology · 2024

DOI: 10.1016/j.vph.2024.107443 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2024. Verfasst von Daniel Wong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cardiovascular Research Center, Department of Internal Medicine, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004,…. Hauptthemen laut MEDLINE: Serum Response Factor, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum Response Factor (SRF) is a critical regulatory transcription factor widely expressed across cell types and is essential for animal survival. Excessive SRF activity has been linked to various pathological conditions and diseases, including cardiovascular diseases, cancers and neurodegenerative disorders, making the inhibition of SRF hyperactivity a promising therapeutic strategy. This review summarizes recent advancements in the discovery and development of SRF inhibitors, their regulatory mechanisms, and their respective molecular foundations. These insights deepen our understanding of current therapeutic potentials, paving the way for novel approaches to treat diseases associated with SRF hyperactivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serum Response FactorSignal TransductionHumansAnimalsMolecular Targeted TherapyCardiovascular Diseases

Stichwörter der Autor:innen

CCGPharmacological inhibitionSerum response factorSignaling

Substanzen

Serum Response FactorSRF protein, human

Autor:innen und Institutionen

  • Translational Cardiovascular Research Center, Department of Internal Medicine, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004, USA. Electronic address: dwong16@asu.edu.
  • Translational Cardiovascular Research Center, Department of Internal Medicine, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004, USA; Clinical Translational Sciences (CTS) and Bio5 Institution, Univ…

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Wong, D., & Qiu, H. (2024). New insights into the pharmacological inhibition of SRF activity: Key inhibitory targets and mechanisms. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2024.107443

Vancouver

Wong D, Qiu H. New insights into the pharmacological inhibition of SRF activity: Key inhibitory targets and mechanisms. Vascular Pharmacology. 2024. doi:10.1016/j.vph.2024.107443

BibTeX
@article{Wong2024,
  author = {Wong, Daniel and Qiu, Hongyu},
  title = {New insights into the pharmacological inhibition of SRF activity: Key inhibitory targets and mechanisms},
  journal = {Vascular Pharmacology},
  year = {2024},
  doi = {10.1016/j.vph.2024.107443}
}
Kostenlos starten →